<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:7pt Arial, sans-serif; }
 .font1 { font:12pt Arial, sans-serif; }
 .font2 { font:9pt Times New Roman, serif; }
 .font3 { font:15pt Times New Roman, serif; }

</style>
</head>
<body>
<p><span class="font3">J.P. Morgan </span><span class="font3" style="font-variant:small-caps;">Cazenove</span></p>
<p><span class="font0" style="font-weight:bold;">CEEMEA Equity Research</span></p>
<p><span class="font0" style="font-weight:bold;">25 November 2020</span></p>
<p><span class="font0" style="font-weight:bold;">Hanzade Kilickiran</span></p>
<p><span class="font0" style="font-weight:bold;">(44 20) 7742 0014</span></p>
<p><a href="mailto:hanzade.kilickiran@jpmorgan.com"><span class="font0" style="font-weight:bold;">hanzade.kilickiran@jpmorgan.com</span></a></p>
<p><span class="font0" style="font-weight:bold;">Other Companies Discussed in </span><span class="font2" style="font-weight:bold;">This </span><span class="font0" style="font-weight:bold;">Report </span><span class="font2" style="font-weight:bold;">(all prices in this report as of market close on 24 November 2020) Gaianti(GARAN.IS/TL9.05/OW), Koc Holding(KCHOL.IS/TL19.06/OW), Migros Ticaret(MGROS.IS/TL40.34/OW), Yapi Kredi(YKBNK.IS/TL2.97/OW)</span></p>
<p><span class="font0" style="font-weight:bold;">Disclosures</span></p>
<p><span class="font0" style="font-weight:bold;">Analyst Certification: The Research Analyses) denoted by an “AC” on the cover of this report certifies (or, where multiple Research Analysts are primarily responsible for this report, the Research Analyst denoted by an “AC” on the cover or within the document individually certifies, with respect to each security or issuer that the Research Analyst covers in this research) that: (1) all of the views expressed in this report accurately reflect the Research Analyst’s personal views about any and all of the subject securities or issuers; and (2) no part of any of the Research Analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the Research Analyst(s) in this report For all Korea-based Research Analysts listed on the front cover, if applicable, they also certify, as per KOFIA requirements, that the Research Analyst’s analysis was made in good faith and that the views reflect the Research Analyst’s own opinion, without undue influence or intervention.</span></p>
<p><span class="font0" style="font-weight:bold;">All authors named within this report are Research Analysts unless otherwise specified. In Europe, Sector Specialists (Sales and Trading) maybe shown on this report as contacts but are not authors of the report or part of the Research Department.</span></p>
<p><span class="font0" style="font-weight:bold;">Important Disclosures</span></p>
<ul style="list-style:none;"><li>
<p><span class="font0" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Market Maker/ Liquidity Provider: J.P. Morgan is a market maker and/or liquidity provider in the financial instruments officiated to Arcelik, Anadolu Efes, Coca-Cola Icecek, Sabanci Holding, Ülker.</span></p></li>
<li>
<p><span class="font0" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Manager or Co-manager: J.P. Morgan acted as manager or co-manager in a public offering of securities or financial instruments (as such term is defined in Directive 2014/65/EU) for Ülker within the past 12 months.</span></p></li>
<li>
<p><span class="font0" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Client: J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients: Arcelik, Anadolu Efes, Coca-Cola Icecek, Sabanci Holding.</span></p></li>
<li>
<p><span class="font0" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Client/Investment Banking: J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as investment banking clients: Sabanci Holding.</span></p></li>
<li>
<p><span class="font0" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Client/Non-Investment Banking, Securities-Related: J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients, and the services provided were non-investment-banking, securities-related: Arcelik, Anadolu Efes, Coca-Cola Icecek, Sabanci Holding, Ülker.</span></p></li>
<li>
<p><span class="font0" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Client/Non-Securities-Related: J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients, and the services provided were non-securities-related: Sabanci Holding.</span></p></li>
<li>
<p><span class="font0" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Investment Banking (past 12 months): J.P. Morgan received in the past 12 months compensation for investment banking services from Sabanci Holding.</span></p></li>
<li>
<p><span class="font0" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Investment Banking (next 3 months): J.P. Morgan expects to receive, or intends to seek, compensation for investment banking services in the next three months from Sabanci Holding.</span></p></li>
<li>
<p><span class="font0" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Non-Investment Banking Compensation: J.P. Morgan has received compensation in the past 12 months for products or services other than investment banking from Arcelik, Anadolu Efes, Coca-Cola Icecek, Sabanci Holding, Ülker.</span></p></li>
<li>
<p><span class="font0" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Debt Position: J.P. Morgan may hold a position in the debt securities of Arcelik, Anadolu Efes, Coca-Cola Icecek, Sabanci Holding, Ülker, if any.</span></p></li></ul>
<p><span class="font0" style="font-weight:bold;">Company-Specific Disclosures: Important disclosures, including price charts and credit opinion history tables, are available for compendium reports and all J.P. Morgan-covered companies by visiting </span><a href="https://www.jpmm.com/reseaidh/disclosures"><span class="font0" style="font-weight:bold;text-decoration:underline;">https://www.jpmm.com/reseaidh/disclosures</span></a><span class="font0" style="font-weight:bold;text-decoration:underline;">,</span><span class="font0" style="font-weight:bold;"> calling 1-800-477-0406, or e-mailing </span><a href="mailto:research.disclosure.mquiries@jpmorgan.com"><span class="font0" style="font-weight:bold;text-decoration:underline;">research.disclosure.mquiries@jpmorgan.com</span></a><span class="font0" style="font-weight:bold;"> with your request. J.P. Morgan’s Strategy, Technical, and Quantitative Research teams may screen companies not covered by J.P. Morgan. For important disclosures for these companies, please call 1-800-477-0406 or e-mail </span><a href="mailto:research.disclosure.inquiries@jpmorgan.com"><span class="font0" style="font-weight:bold;text-decoration:underline;">research.disclosure.inquiries@jpmorgan.com</span></a><span class="font0" style="font-weight:bold;">.</span></p>
<p><span class="font0" style="font-weight:bold;">Explanation of Equity Research Ratings, Designations and Analyses) Coverage Universe:</span></p>
<p><span class="font0" style="font-weight:bold;">J.P. Morgan uses the following rating system: Overweight [Over the next six to twelve months, we expect this stock will outperform the average total return of the stocks in the analyst’s (or the analyst’s team’s) coverage universe.] Neutral [Over the next six to twelve months, we expect this stock will perform in line with the average total return of the stocks in the analyst’s (or the analyst’s team’s) coverage universe.] Underweight [Over the next six to twelve months, we expect this stock will underperform the average total return of the stocks in the analyst’s (or the analyst’s team’s) coverage universe.] Not Rated (NR): J.P. Morgan has removed the rating and, if applicable, the price target, for this stock because of either a lack of a sufficient fundamental basis or for legal, regulatory or policy reasons. The previous rating and, if applicable, the price target, no longer should be relied upon. An NR designation is not a</span></p>
<p><span class="font0" style="font-weight:bold;">35</span></p>
<div>
</div><br clear="all">
<p><span class="font1">This document is being provided for the exclusive use of </span><a href="mailto:korhan.c.yagiz@jpmorgan.com"><span class="font1">korhan.c.yagiz@jpmorgan.com</span></a><span class="font1"> &amp;&nbsp;clients of J.P. Morgan.</span></p>
</body>
</html>